Home Blog Page 2372

Geely Riddara Launches RD6 Econ All-electric Pickup in Southeast Asia


HANGZHOU, CHINA – Media OutReach Newswire – 3 October 2025 – Geely Riddara launches the RD6 Econ all-electric pickup in Laos and the Philippines, with rollouts to Thailand, Malaysia, and Pakistan—Positioned as an economical, dual-use pickup for commercial and personal needs, the RD6 Econ combines outstanding cost efficiency with optimized energy consumption to offer global markets a more sustainable, value-driven choice.

Geely Riddara Launches RD6 Econ All-electric Pickup in Southeast Asia
Geely Riddara Launches RD6 Econ All-electric Pickup in Southeast Asia

The RD6 “Econ” designation derives from “Economic,” reflecting the pickup’s core values of being Eco-Friendly, Efficient and Economical. With the five major advantages of “Economy, Power, Loading Capacity , Maneuverability and Safety”, this model focuses on commercial scenarios, while taking into account the multi-functional needs of family use. The RD6 Econ completely overturns the pain points of traditional fuel pickups such as high energy consumption, low response, and high maintenance.

Economy — Compared with ICE pickups, the RD6 Econ achieves significantly lower running costs in energy and maintenance, with measured consumption as low as 16.2 kWh/100 km.

Power — With a maximum output of 280 kW and peak torque of 485 N·m, the 4WD system ensures confident performance on rugged climbs.

Loading Capacity — A 1,765 mm truck bed and a 1,235 kg loading capacity meet heavy-duty needs; STC surface treatment adds wear resistance and anti-corrosion protection for high-humidity coastal use.

Maneuverability —A 6.1 m minimum turning radius (0.4 m tighter than mainstream ICE pickups) enhances agility in narrow alleys and work sites, while the exceptionally quiet cabin elevates extended driving comfort.

Safety — An integrated skeleton body (70% high-strength steel; 30,300 N·m/deg body torsional stiffness) and 225 mm ground clearance help withstand potholes, gravel, and site scrapes.

Geely Riddara has been China’s No. 1 NEV pickup brand for three consecutive years. This achievement reflects broad user trust and support. Building on this foundation, the RD6 Econ (BEV) and RD6 PHEV establish a “BEV + PHEV” dual-technology lineup that complements existing offerings in Southeast Asia, Latin America and Africa, broadens choice in value-driven commercial segments, and accelerates the electrification of regional commercial pickup markets.

Advancing its “Tech-driven, Scenario-defined” strategy, Geely Riddara pairs this lineup with localized energy and service solutions to reduce energy consumption and optimize total cost of ownership. With the RD6 Econ at its core, Geely Riddara brings better choices to the global commercial pickup market, expanding practical options for fleets and businesses.

Hashtag: #GeelyRiddara

The issuer is solely responsible for the content of this announcement.

Agoda Launches New Program to Partner with Travel Creators and Drive Bookings

BANGKOK, Oct. 3, 2025 /PRNewswire/ — Digital travel platform Agoda has launched the Agoda Ambassador program, a new initiative designed to strengthen commercial ties with travel creators on social media. The initiative will see Agoda working directly with travel creators to inspire their audiences to book travel through the platform.

Agoda Ambassador Program
Agoda Ambassador Program

Under the program, participating travel creators will be given unique promo codes to share with their followers. For every booking made with these codes, they will receive a commission. Agoda will also offer sponsored stays and activities valued at up to USD 225 per month enabling them to showcase first-hand experiences of Agoda’s partner hotels and destinations of their choice. The program also aims to enhance exposure for creators by featuring them in Agoda campaigns, thereby expanding their reach.

Matteo Frigerio, Chief Marketing Officer at Agoda, shared, “Travel creators play an increasingly important role in how travelers discover and choose their next trip. By giving them the tools to share authentic experiences and rewarding them for the bookings they generate, we’re building a partnership model that benefits travel creators, travelers and our hotel partners alike.”

Rewards range from earning profits and receiving exclusive Agoda swag packs to winning special trophies and accumulating travel credits of up to USD 1,000. Agoda’s offerings include over 6 million holiday properties, more than 130,000 flight routes, and over 300,000 activities, all of which can be combined in the same booking. Creators can explore and sign up on the Agoda Ambassador page via Agoda.com/agoda-ambassador.

— ENDS —

Nutromics unveils world-first real-time in vivo multiplexing data at IATDMCT

MELBOURNE, Australia, Oct. 3, 2025 /PRNewswire/ — Diagnostics company Nutromics has presented the world’s first real-time, continuous data on two critical antibiotics – vancomycin and tobramycin – measured simultaneously on the same device in animal models. The breakthrough was unveiled at the International Congress of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) in Singapore.

The study, conducted in rats, demonstrated the Nutromics platform’s ability to continuously track levels of multiple targets on the one device (‘multiplexing’). Both vancomycin, among the most frequently dosed IV antibiotics in U.S. hospitals, and tobramycin, one of the 300 most commonly prescribed U.S. drugs, are frontline treatments for infections such as sepsis and MRSA. While lifesaving, they pose risks: overdosing can cause nephrotoxicity, while underdosing fuels antimicrobial resistance. Real-time monitoring will enable clinicians to optimize dosing for safety and efficacy.

“Our goal is to start providing real-time molecular data in critical care settings,” said COO Hitesh Mehta. “Clinicians often tell us that today they are currently flying blind, relying on delayed point-in-time data. The Nutromics Lab-on-a-Patch® has the potential to transform healthcare, starting with how we approach Therapeutic Drug Monitoring. Demonstrating multiplexing proves this technology is a true platform and affirms Nutromics’ larger goal: real-time data for drugs and biomarkers, aiding clinicians in other areas such as cardiology and triage – and following the patient seamlessly from hospital to hospital in home care and broader community settings.”

To achieve dual detection, the Nutromics team deployed a wearable patch with microneedles coated in synthetic DNA-based sensors (or aptamers), one specific to vancomycin, the other tobramycin. Each aptamer responded selectively to its target drug without interference when both were administered at separate time points, demonstrating both sensitivity and specificity. The devices were fabricated using the same process Nutromics’ uses today for a single sensor device in its ongoing human studies.

“While numerous biosensors have been shown to work in a beaker, transitioning from bench to body requires the technology to function reliably and accurately under diverse, dynamic biological conditions outside of a controlled lab environment. This is often where failure occurs.,” said lead scientist Julian Gerson. “Building on the validation of our lead sensor for vancomycin in first-in-human studies over the last two years, this work further demonstrates Nutromics’ ability to translate aptamer technologies from bench to in vivo. Importantly, we are the first to show multiplexed measurement of antibiotics in vivo, something existing technologies have not achieved. By proving this is not only possible but high-fidelity, Nutromics is now adding high-value biomarkers to its sensor library, moving towards diagnostic ‘panels’ that can give doctors the critical information they need in real time.”

In August, the company announced A$7.5 million in new funding and has already completed first-in-human studies with its wearable patches. Clinical trials in multiple hospital ICUs are now underway in Australia, with US hospital trials slated for 2026.

GORDON & MACPHAIL REVEALS ‘ARTISTRY IN OAK’ DECANTER DESIGN BY ACCLAIMED ARCHITECT JEANNE GANG FOR THE WORLD’S OLDEST SINGLE MALT SCOTCH WHISKY

ELGIN, Scotland, Oct. 3, 2025 /PRNewswire/ — Gordon & MacPhail has revealed the ‘Artistry in Oak’ decanter design by internationally acclaimed American architect Jeanne Gang, marking the release of the oldest single malt Scotch ever bottled – Gordon & MacPhail 85 Years Old from Glenlivet Distillery.

 

Gordon & MacPhail 85 Years Old from Glenlivet Distillery – Credit: GORDON & MACPHAIL

Gordon & MacPhail sought to commission a creative partner to design a unique decanter to house their most precious whisky to date. A partnership built on common values and a shared commitment to leave a legacy for future generations, Jeanne Gang’s design is shaped through her close observation of growth and form in nature. The four branches which suspend the glass decanter are made from solid bronze, providing an armature that cradles the precious liquid in the same way the oak cask has nurtured the whisky for eight and a half decades.

Only 125 decanters are available worldwide, each with an RSP of £125,000.

Over the last 130 years, Gordon & MacPhail has been driven by a simple mission: to create single malt Scotch whisky of exceptional quality. Through four generations of family ownership, the company has matched its own specially selected casks with spirit from over 100 Scottish distilleries. Managing a portfolio of casks requires a complex level of expertise which Gordon & MacPhail has honed to fully understand cask maturation matched to different styles of spirit. Patience is undoubtedly a virtue in this realm and Gordon & MacPhail’s whiskies are often the oldest expression ever to be released from a particular distillery.

The decanter design by Jeanne Gang is a celebration of the profound artistry, craft, care and time alongside nature that went into the liquid it encases. The maturation of whisky over very long periods of time is a very challenging proposition often quoted as more art than science. As the oldest single malt Scotch ever bottled, this release is the ultimate expression of this art and testament to the foresight of George Urquhart and his father, John, who selected cask 336 in 1940 to cradle this liquid for decades to come.

“One of the greatest challenges was that this has never been done before. We’re the first to mature a whisky for 85 years. Every year that goes by is a year into the unknown. We have to appreciate we’re always dealing with mother nature so the key traits of this process are patience and trust,” comments Stephen Rankin Director of Prestige at Gordon & MacPhail, and member of the fourth generation of the family that owns the company.

Embracing the creative theme of ‘Artistry in Oak’, the design evokes the idea of a tree slowly entwining a piece of amber. Four separate branches spiral upward, wrapping around a suspended glass vessel that contains the amber liquid originally distilled at Glenlivet Distillery. American oak informed the branches’ design, a nod to the wood used to comprise the Gordon & MacPhail cask which cradled the spirit for 85 years.

“It was of utmost importance that the quality of the whisky itself be manifest in the design of the decanter. Made from handblown glass and cast bronze, I thought about how each material would exhibit its own inherent qualities while fulfilling its purpose to hold and protect the liquid,” explains Jeanne Gang.

The design was conceived as a single object, with the suspended glass vessel relying on the branches for support, evoking the reciprocity between whisky and its cask.  Jeanne chose bronze for the four entwining branches that cradle the vessel because it is an enduring material; one that evolves slowly and beautifully over time, much like whisky. As bronze develops a patina, it mirrors the way whisky deepens in colour and character over the years.

“Standing tall and strong, the patinated bronze entwines the vessel, suspending it while revealing the amber colour of the whisky within. Together, the elements depend on and complement each other, in a reciprocal dance whose form, like the whisky it holds, is a product of both natural growth and the nature of its materiality,” expresses Gang.

As part of this landmark release, Gordon & MacPhail is supporting American Forests, the oldest national non-profit conservation organisation in the United States – a leader in forest restoration – via the online auction of Decanter #1 in partnership with Christie’s.

“Given the importance of oak in our craft, this partnership was a natural fit, aligning with our mission to leave a meaningful legacy for ongoing generations via fundraising for the sustainable future of American oak trees,” adds Stephen Rankin.

The auction conducted online by Christie’s, opening for bids on Friday 7th November and concluding on Friday 21st November 2025, will see proceeds of the lot (minus costs) donated to the American Forests, to support their work dedicated to creating healthy and resilient forests in cities and large landscapes, including the regeneration and long-term sustainability of America’s oak-dominated forests essential for whisky maturation.

As well as Decanter #1, the lot will include a personalised whisky tasting hosted by Gordon & MacPhail’s Director of Prestige Stephen Rankin or Richard Urquhart, Sales Director, both fourth generation family members; a framed, signed sketch of an oak tree by Jeanne Gang, which informed the decanter’s design; and the cask end of cask 336 which nurtured the single malt Scotch whisky, presented in a bespoke frame.

Adam Bilbey, Christie’s Global Head of Wine and Spirits says: “Partnering with Gordon & MacPhail for Artistry in Oak is a moment of pride for Christie’s. The unveiling of Decanter No. 1 from Gordon & MacPhail 85 Years Old is not just a highlight of our season—it’s a celebration of time, tradition, and craftsmanship. Over the last 85yrs this extraordinary spirit has been carefully and patiently nurtured by Gordon & MacPhail, culminating in the extraordinary moment.”

A TASTE OF LIQUID HISTORY

At 85 years old, this historical liquid has spent decades maturing in a unique cask that has had a profound impact on its flavour. Cask 336 had previously held mature sherry before being re-filled on 3 February 1940 with spirit at the Glenlivet Distillery. This was a time when production across Scotland was much reduced due to the raw materials required being diverted for other uses or there being a shortage in them created by the war.

This long maturation has imparted deep, complex flavours to the whisky, with vibrant, full-bodied notes that remain remarkably robust at 43.7% ABV. The influence of the cask, combined with the rarity and incredible scarcity of the liquid, creates a whisky that is not only extraordinary in its taste but also a living piece of history.

Aroma: Soft, aged leather aromas lead to apricot compote, cinnamon, and subtle waxy, citrus fruit notes. Vanilla gives way to dried sultana and aniseed with underlying beeswax polish. Subtle smoky undertones develop.

Flavours: Smooth and vibrant with cracked black pepper and sweet dried tobacco flavours, followed by Seville Orange peel. Morello cherry and plum flavours are balanced by subtle oak.

Finish: A full-bodied finish with lingering herbal notes.

This exceptional release represents the pinnacle of whisky craftsmanship – an 85-year-old single malt matured over four generations. Not only is it the oldest whisky ever bottled, but its extreme rarity, scarcity and provenance, coupled with the artistry of Jeanne Gang’s design, make it an unparalleled collector’s piece.

Gordon & Macphail 85 Years Old From Glenlivet Distillery
Available worldwide, priced at £125,000
WWW.GORDONANDMACPHAIL.COM

Christie’s Online Auction of Decanter #1
Bidding opens Friday 7 November and closed Friday 21 November 2025
Proceeds of the lot (minus costs) donated to the American Forests
WWW.CHRISTIES.COM

@GORDONANDMACPHAIL

Gordon & MacPhail 85 Years Old from Glenlivet Distillery – Credit: GORDON & MACPHAIL
Gordon & MacPhail 85 Years Old from Glenlivet Distillery – Credit: GORDON & MACPHAIL

 

Jeanne Gang and Gordon & MacPhail 85 Years Old from Glenlivet Distillery Decanter – Credit: GORDON & MACPHAIL
Jeanne Gang and Gordon & MacPhail 85 Years Old from Glenlivet Distillery Decanter – Credit: GORDON & MACPHAIL

 

Cask End 336, Gordon & MacPhail 85 Years Old from Glenlivet Distillery – Credit: GORDON & MACPHAIL
Cask End 336, Gordon & MacPhail 85 Years Old from Glenlivet Distillery – Credit: GORDON & MACPHAIL

 

Gordon & MacPhail 85 Years Old from Glenlivet Distillery – Credit: GORDON & MACPHAIL
Gordon & MacPhail 85 Years Old from Glenlivet Distillery – Credit: GORDON & MACPHAIL

 

 

MedHub-AI Announces National Reimbursement Approval in Japan for AutocathFFR™

TEL AVIV, Israel, Oct. 3, 2025 /PRNewswire/ — MedHub-AI today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved national reimbursement for the company’s AutocathFFR™ System, effective October 1, 2025. The decision follows regulatory approval by the Pharmaceuticals and Medical Devices Agency (PMDA) earlier this year and marks a significant milestone in expanding access to advanced coronary physiology assessment in Japan.

The approval provides physicians and hospitals across Japan with broad access to AutocathFFR, the first fully automated, real-time AI-based fractional flow reserve (FFR) solution performed intra-procedurally during coronary angiography. By removing the need for pressure wires or hyperemic agents, AutocathFFR integrates seamlessly into the cath lab workflow, enabling fast and precise assessment of coronary artery disease (CAD).

Addressing a Critical Healthcare Need

Coronary artery disease is the number one cause of morbidity and mortality worldwide, including in Japan where the burden of cardiovascular disease continues to rise. The introduction of AI-driven, non-invasive physiology represents an important advancement for both clinicians and patients by supporting evidence-based decision-making, reducing procedural complexity, and potentially lowering overall healthcare costs.

With reimbursement now established, AutocathFFR is positioned to play a central role in improving access to advanced CAD assessment throughout Japan. This milestone further strengthens MedHub-AI’s strategic collaboration with Terumo Corporation to accelerate adoption and integration of AutocathFFR across hundreds of hospitals nationwide.

Differentiation from 3D-Based FFR Solutions

Unlike 3D image reconstruction-based physiology technologies that require complex processing, manual steps, and time-consuming analysis, AutocathFFR is fully automated and does not rely on 3D modeling of coronary anatomy. Instead, it applies advanced AI algorithms directly to routine angiographic images, producing physiology results instantly and reproducibly within the procedure.

This unique approach reduces operator dependency, shortens analysis time, and enhances consistency across patients and centers. These advantages make AutocathFFR ideally suited for broad adoption in daily practice, ensuring that physiology assessment is available for every case, not just selected patients.

Advancing Global Strategy

“Reimbursement approval in Japan represents a major achievement for MedHub-AI and validates the clinical and economic value of AutocathFFR,” said Or Bruch-El, Chief Executive Officer of MedHub-AI. “This milestone underscores our commitment to advancing coronary physiology worldwide and to ensuring that patients and physicians have access to innovative, AI-driven solutions that transform clinical practice.”

About AutocathFFR™

AutocathFFR is the first fully automated AI-based system that enables real-time, intra-procedural physiology assessment during coronary angiography. The system is:

  • Non-invasive: Requires no pressure wires or pharmacologic hyperemia.
  • Fast and efficient: Provides results in seconds in real time without disrupting workflow.
  • Reproducible: Automated AI eliminates variability and ensures consistent results.
  • Clinically validated: Multi-center studies have demonstrated equivalence to invasive FFR methods.

AutocathFFR has received regulatory approvals in Japan and is part of MedHub-AI’s broader global strategy to expand access to AI-driven solutions for cardiovascular care.

Contacts:
MedHub
Or Bruch-El, Founder & CEO
Email: Or@medhub-ai.com

Yarden Bruch-El, COO
Email: Yarden@medhub-ai.com
Website: www.MedHub-AI.com 

Logo: https://laotiantimes.com/wp-content/uploads/2025/10/medhub_logo.jpg

 

Emeren Group Announces Cancellation and Rescheduling of Extraordinary General Meeting

NORWALK, Conn., Oct. 3, 2025 /PRNewswire/ — Emeren Group Ltd (“Emeren” or the “Company“) (www.emeren.com) (NYSE: SOL), a leading global solar and storage project developer, owner, and operator, today announced that its extraordinary general meeting previously scheduled to be held at 10:00 a.m. Eastern Standard Time on October 21, 2025 (the “Previously Scheduled EGM“), to consider and vote on, among other things, the proposal to authorize and approve the Agreement and Plan of Merger (as amended), dated as of June 18, 2025, by and among the Company, Shurya Vitra Ltd., and Emeren Holdings Ltd, and the transactions contemplated thereby (the “Merger Proposal“), is cancelled with immediate effect, and the Company plans to announce the date of a new extraordinary general meeting (the “New EGM“) to consider and vote on, among other things, the Merger Proposal, as soon as it has finalized and filed the definitive proxy statement on Schedule 14A and the definitive transaction statement on Schedule 13E-3 related to the Merger Proposal.

As previously announced on September 2, 2025, the date of the Previously Scheduled EGM is subject to postponement depending on the review by the U.S. Securities and Exchange Commission (the “SEC“) of the proxy statement on Schedule 14A and the transaction statement on Schedule 13E-3 related to the Merger Proposal filed by the Company on September 2, 2025. In light of the time it would require to make further amendments to these filings, the Company decided to cancel the Previously Scheduled EGM and convene a New EGM on a later date to consider and vote on, among other things, the Merger Proposal. The Company will provide notice of the New EGM, including the record date for the New EGM, in accordance with relevant laws and regulations and the Company’s memorandum and articles of association.

About Emeren Group Ltd

Emeren Group Ltd (NYSE: SOL), a renewable energy leader, showcases a comprehensive portfolio of solar and storage projects and Independent Power Producer (IPP) assets, complemented by a significant global Battery Energy Storage System (BESS) capacity. Specializing in the entire solar project lifecycle — from development through construction to financing — we excel by leveraging local talent in each market, ensuring our sustainable energy solutions are at the forefront of efficiency and impact. Our commitment to enhancing solar power and energy storage underlines our dedication to innovation, excellence, and environmental responsibility. For more information, go to www.emeren.com.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “targets, “confident” and similar statements. Among other things, statements that are not historical facts, including statements about Emeren’s beliefs and expectations, the business outlook and quotations from management in this announcement, as well as Emeren’s strategic and operational plans, are or contain forward-looking statements. Emeren may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in its periodic reports to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. All forward-looking statements are based upon management’s expectations at the time of the statements and involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: execution of Emeren’s strategies and business plans; growth and trends of the industries in which Emeren operates; market acceptance of Emeren’s products and services; competition in the industries in which Emeren operates; Emeren’s ability to control costs and expenses; Emeren’s ability to retain key personnel and attract new talent; relevant government policies and regulations relating to Emeren’s industry, corporate structure and business operations; seasonality in the business; fluctuations in currencies exchange rates; risks related to acquisitions or investments Emeren has made or will make in the future; accounting adjustments that may occur during the quarterly or annual close or auditing process; and fluctuations in general economic, political, geopolitical and business conditions. Further information regarding these and other risks are included in Emeren’s filings with the U.S. Securities and Exchange Commission. All information provided in this press release and in the attachments is as of the date of the press release and based on assumptions that Emeren believes to be reasonable as of this date, and Emeren undertakes no obligation to update any forward-looking statement, except as required under applicable law.

For investor and media inquiries, please contact:

Emeren Group Ltd – Investor Relations
ir@emeren.com 

Bybit Lists DoubleZero (2Z), Bringing Infrastructure-Backed Token to Traders With 5.5M 2Z Launch Promotion

DUBAI, UAE, Oct. 3, 2025 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, has listed DoubleZero (2Z), the token supporting a dedicated low-latency networking layer currently used by more than 300 blockchain validators worldwide. The listing introduces 2Z trading against both USDT and USDC, providing Bybit users access to an infrastructure-based asset designed to enhance block propagation, validator fairness and overall network reliability across distributed systems.

Backed by the Solana ecosystem, 2Z is a top-tier project on Solana led by Austin, a former member of the Solana Foundation.

DoubleZero takes a physical approach to blockchain scaling. Instead of relying solely on software-level improvements, it operates a permissionless fiber network in which data is routed directly between nodes via independently managed links. This enables faster packet transmission compared to conventional internet pathways, reducing consensus delays and improving performance for validators across diverse geographies. By combining fiber links run by independent contributors with edge filtering hardware in a permissionless network, DoubleZero maintains crypto-economic security guarantees while improving throughput.

Deposits for 2Z opened on October 2 at 4:00 a.m. UTC. Trading for the 2Z/USDT pair went live at 1:00 p.m. UTC, followed by 2Z/USDC at 1:30 p.m. Withdrawals are scheduled to open on October 3 at 10:00 a.m. UTC.

To coincide with the listing, Bybit has launched a 5.5 million 2Z “Token Splash” promotion. A total of 2,000,000 2Z has been allocated exclusively to new users through a deposit-based campaign running between October 2 and October 10. The first 5,000 participants who meet the qualifying thresholds—either by depositing 2,000 2Z or depositing and trading the equivalent of 100 USDT—will each receive 400 2Z.

An additional 3,500,000 2Z has been reserved for trading rewards, open to all users who meet eligibility criteria.  Between October 2 at 1:00 p.m. UTC and October 10 at 11:00 a.m. UTC, any user who reaches a cumulative total of 500 USDT or more in 2Z spot trading volume will qualify for proportional rewards, with payouts capped at 1,800 2Z per participant.

The listing of 2Z reflects Bybit’s continued focus on onboarding tokens backed by real-world infrastructure usage. As blockchain networks expand, performance improvements at the physical transport layer are becoming increasingly relevant to both institutional and retail participants. DoubleZero’s approach to network acceleration offers a clear example of how hardware-aligned protocols are beginning to play a foundational role in blockchain scalability.

#Bybit / #TheCryptoArk

About Bybit

Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving a global community of over 70 million users. Founded in 2018, Bybit is redefining openness in the decentralized world by creating a simpler, open and equal ecosystem for everyone. With a strong focus on Web3, Bybit partners strategically with leading blockchain protocols to provide robust infrastructure and drive on-chain innovation. Renowned for its secure custody, diverse marketplaces, intuitive user experience, and advanced blockchain tools, Bybit bridges the gap between TradFi and DeFi, empowering builders, creators, and enthusiasts to unlock the full potential of Web3. Discover the future of decentralized finance at Bybit.com.

For more details about Bybit, please visit Bybit Press

For media inquiries, please contact: media@bybit.com

For updates, please follow: Bybit’s Communities and Social Media

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

CCTV4: Heritage and Harmony Beneath the Full Moon, The World Is Invited to the CMG 2025 Mid-Autumn Festival Gala

BEIJING, Oct. 3, 2025 /PRNewswire/ — This year, for its Mid-Autumn Festival Gala, China Media Group invites you to Deyang in the country’s southwest – a city where ancient tradition merges with a vision of a high-tech future.

Heritage and Harmony Beneath the Full Moon :The World Is Invited to the CMG 2025 Mid-Autumn Festival Gala
Heritage and Harmony Beneath the Full Moon :The World Is Invited to the CMG 2025 Mid-Autumn Festival Gala

Set amid the stunning natural scenery of Sichuan Province, the Gala will feature songs, old and new, focusing on the Festival’s core theme of missing home and family reunion at the time of the full moon. In an acknowledgement of the recent 80th anniversary of victory in the Chinese People’s War of Resistance Against Japanese Aggression and the World Anti-Fascist War, performances of the nostalgic classics “Flowers of May”, “As Time Goes By” and “La Vie en Rose” will reinforce the theme of humanity’s shared sentiments of cherishing peace and aspiring for a bright new dawn. Underscoring the power of music to bring the world together will be an innovative fusion of “The Moon Represents My Heart” and Ben E. King’s “Stand by Me”, performed by Grammy-Award-winning band Time for Three and Chinese singer Jike Junyi.

Deyang, as a modern manufacturing hub and gateway to the ancient Kingdom of Shu and its mysterious Sanxingdui culture, is a place where tradition and innovation not only coexist, but reinforce each other. In a striking episode designed to highlight this harmony, the Gala will tour the Sanxingdui Museum in the company of a robot which, by interacting with the artifacts, will create a dialogue between China’s intelligent manufacturing and ancient civilization.

The 2025 CMG Mid-Autumn Festival Gala will be broadcast around the world, from 8pm Beijing Time on October 6.